196 related articles for article (PubMed ID: 26214803)
1. Significant Correlation between Retinal Venous Tortuosity and Aqueous Vascular Endothelial Growth Factor Concentration in Eyes with Central Retinal Vein Occlusion.
Yasuda S; Kachi S; Kondo M; Ueno S; Kaneko H; Terasaki H
PLoS One; 2015; 10(7):e0134267. PubMed ID: 26214803
[TBL] [Abstract][Full Text] [Related]
2. Electroretinograms and level of aqueous vascular endothelial growth factor in eyes with hemicentral retinal vein occlusion or branch retinal vein occlusion.
Yasuda S; Kachi S; Ueno S; Ushida H; Piao CH; Kondo M; Terasaki H
Jpn J Ophthalmol; 2014 May; 58(3):232-6. PubMed ID: 24668132
[TBL] [Abstract][Full Text] [Related]
3. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
[TBL] [Abstract][Full Text] [Related]
4. Significant correlation between electroretinogram parameters and ocular vascular endothelial growth factor concentration in central retinal vein occlusion eyes.
Yasuda S; Kachi S; Kondo M; Ushida H; Uetani R; Terui T; Piao CH; Terasaki H
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5737-42. PubMed ID: 21642626
[TBL] [Abstract][Full Text] [Related]
5. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion.
Park SP; Ahn JK
Clin Exp Ophthalmol; 2009 Jul; 37(5):490-5. PubMed ID: 19624346
[TBL] [Abstract][Full Text] [Related]
6. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
Wen J; Jiang Y; Zheng X; Zhou Y
Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235
[TBL] [Abstract][Full Text] [Related]
7. Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion.
Matsushima R; Noma H; Yasuda K; Goto H; Shimura M
J Ocul Pharmacol Ther; 2019 Sep; 35(7):407-412. PubMed ID: 31373873
[No Abstract] [Full Text] [Related]
8. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
Noma H; Mimura T; Yasuda K; Shimura M
Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
[TBL] [Abstract][Full Text] [Related]
10. Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma.
Sin BH; Song BJ; Park SP
J Glaucoma; 2013 Feb; 22(2):104-9. PubMed ID: 21946550
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
12. Influence of ocular volume and lens status on pharmacokinetics and duration of action of intravitreal vascular endothelial growth factor inhibitors.
Krohne TU; Muether PS; Stratmann NK; Holz FG; Kirchhof B; Meyer CH; Fauser S
Retina; 2015 Jan; 35(1):69-74. PubMed ID: 25077535
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.
Cui W; Sun XY; Sun LP; Li J; Liu ZL; Zhang H
J Ocul Pharmacol Ther; 2021; 37(1):52-59. PubMed ID: 33216685
[No Abstract] [Full Text] [Related]
14. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
Kim JH; Shin JP; Kim IT; Park DH
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
[TBL] [Abstract][Full Text] [Related]
15. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion.
Yasuda S; Kachi S; Ueno S; Piao CH; Terasaki H
Acta Ophthalmol; 2015 Sep; 93(6):e465-8. PubMed ID: 25597703
[TBL] [Abstract][Full Text] [Related]
16. Monitoring ocular drug therapy by analysis of aqueous samples.
Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion.
Pfau M; Fassnacht-Riederle H; Becker MD; Graf N; Michels S
Ophthalmic Res; 2015; 54(3):150-6. PubMed ID: 26413794
[TBL] [Abstract][Full Text] [Related]
18. Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia.
Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
J Fr Ophtalmol; 2016 Dec; 39(10):816-821. PubMed ID: 27865689
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Eur J Ophthalmol; 2010; 20(2):402-9. PubMed ID: 19967679
[TBL] [Abstract][Full Text] [Related]
20. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.
Campochiaro PA; Hafiz G; Shah SM; Nguyen QD; Ying H; Do DV; Quinlan E; Zimmer-Galler I; Haller JA; Solomon SD; Sung JU; Hadi Y; Janjua KA; Jawed N; Choy DF; Arron JR
Mol Ther; 2008 Apr; 16(4):791-9. PubMed ID: 18362932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
